Tier 2 · Liquid 3000
Corvus Pharmaceuticals, Inc.
CRVS · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.
Price
$14.46
+0.00%
Coverage
Tier 2
Tier 2 · Liquid 3000
SEC CIK
0001626971
Liquidity rank
#2848
Observed dollar volume
SEC XBRL facts
| Field | Value | Period end | Filing |
|---|---|---|---|
| Annual revenue | Not published | Not published | No matching frame |
| Annual diluted EPS | -0.53 | 2025-12-31 | 0001104659-26-027047 |
| Quarterly revenue | Not published | Not published | No matching frame |
| Quarterly diluted EPS | -0.19 | 2026-06-30 | 0001104659-26-091975 |
SEC EDGAR Frames batch generated 2026-08-23T22:53:06.929Z. Frames are calendar-aligned and may not cover every filer or fiscal period.
Dividends
Trailing 12 months
Not published
Latest payment
Not published
Yahoo Finance corporate actions. Window: 2025-08-24 through 2026-08-24.
Seasonality
| Month | Mean return | Positive | n |
|---|
Monthly close-to-close returns, trailing 15 years where Yahoo history is available.
Sector news
No matching sector headlines were returned in the 72-hour window.
Filings and machine access
Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract
Context paths
HealthcareNasdaqBMY · Tier 1 peerISRG · Tier 1 peerHCA · Tier 1 peerAMGN · Tier 1 peer
Provenance
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames